Literature DB >> 18553046

Fundus rotation gastroplasty vs. Kirschner-Akiyama gastric tube in esophageal resection: comparison of perioperative and long-term results.

Werner Hartwig1, Oliver Strobel, Lutz Schneider, Thilo Hackert, Christine Hesse, Markus W Büchler, Jens Werner.   

Abstract

BACKGROUND: Improved tube length and low anastomotic leakage rates have been demonstrated for fundus rotation gastroplasty (FRG) after esophageal resection. The aim of the present study was to compare the safety of FRG vs. the conventional Kirschner-Akiyama gastric tube in a large prospective clinical series.
METHODS: All patients with primary esophageal cancer who were to undergo esophageal resection at the authors' department were prospectively assessed. The subgroup of patients in whom FRG or the Kirschner-Akiyama reconstruction with either intrathoracic or cervical anastomosis was performed between October 2001 and November 2005 was analyzed for perioperative surgical and nonsurgical complications and for long-term survival.
RESULTS: FRG was performed in 57 patients and Akiyama reconstruction was performed in 54 patients with potentially curative resectable carcinoma. The patients had a mean age of 60.3 years. Tumor type was squamous cell carcinoma in 51 patients and adenocarcinoma (AEG types I and II) in 60 patients. There were no differences between the reconstruction groups with respect to age, gender, tumor type, neoadjuvant treatment, and tumor stage. Duration of surgery, blood loss, resection margins, extent of lymphadenectomy, ICU stay, and hospital stay also did not show any significant differences. Overall leakage rate, including tube ischemia, was 9.9% and mortality was 2.7%. Compared with the Akiyama reconstruction, FRG was performed significantly more often in combination with cervical anastomosis (4 vs. 22, respectively, p = 0.0001). Uni- and multivariate analyses excluded the reconstruction type as a possible parameter for insufficiency. Furthermore, neither hospital mortality nor long-term survival was significantly different between the two groups.
CONCLUSION: This clinical series is the first to compare FRG and conventional gastric tube reconstruction after esophagectomy in esophageal cancer. With comparable perioperative and long-term results of either technique, the increased length of the FRG tube may have advantages for reconstruction with cervical anastomosis.

Entities:  

Mesh:

Year:  2008        PMID: 18553046     DOI: 10.1007/s00268-008-9648-z

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  32 in total

1.  Handsewn or stapled esophagogastric anastomoses after esophagectomy for cancer: meta-analysis of randomized controlled trials.

Authors:  J D Urschel; C J Blewett; W F Bennett; J D Miller; J E Young
Journal:  Dis Esophagus       Date:  2001       Impact factor: 3.429

2.  The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction.

Authors:  S M Dresner; P J Lamb; M K Bennett; N Hayes; S M Griffin
Journal:  Surgery       Date:  2001-01       Impact factor: 3.982

3.  Intrathoracic manifestations of cervical anastomotic leaks after transthoracic esophagectomy for carcinoma.

Authors:  Robert J Korst; Jeffrey L Port; Paul C Lee; Nasser K Altorki
Journal:  Ann Thorac Surg       Date:  2005-10       Impact factor: 4.330

4.  Comparison of hand-sewn and stapled esophagogastric anastomosis after esophageal resection for cancer: a prospective randomized controlled trial.

Authors:  S Law; M Fok; K M Chu; J Wong
Journal:  Ann Surg       Date:  1997-08       Impact factor: 12.969

5.  Esophagoplasty with an autogenous tubed gastric flap.

Authors:  T Yamato; Y Hamanaka; S Hirata; K Sakai
Journal:  Am J Surg       Date:  1979-05       Impact factor: 2.565

6.  Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus.

Authors:  J F Bosset; M Gignoux; J P Triboulet; E Tiret; G Mantion; D Elias; P Lozach; J C Ollier; J J Pavy; M Mercier; T Sahmoud
Journal:  N Engl J Med       Date:  1997-07-17       Impact factor: 91.245

7.  Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction.

Authors:  C van de Ven; P De Leyn; W Coosemans; D Van Raemdonck; T Lerut
Journal:  Eur J Cardiothorac Surg       Date:  1999-06       Impact factor: 4.191

8.  Preoperative embolization of gastric arteries for esophageal cancer.

Authors:  S Akiyama; S Ito; H Sekiguchi; M Fujiwara; J Sakamoto; K Kondo; Y Kasai; K Ito; H Takagi
Journal:  Surgery       Date:  1996-09       Impact factor: 3.982

9.  Diagnostic, therapeutic, and prognostic features of cancers of the esophagus: results of the international prospective study conducted by the OESO group (790 patients).

Authors:  R Giuli; H Sancho-Garnier
Journal:  Surgery       Date:  1986-05       Impact factor: 3.982

10.  Anastomotic complications after esophagectomy for cancer. A comparison of neck and chest anastomoses.

Authors:  T C Lam; M Fok; S W Cheng; J Wong
Journal:  J Thorac Cardiovasc Surg       Date:  1992-08       Impact factor: 5.209

View more
  3 in total

1.  Expression of MMP9, SERPINE1 and miR-134 as prognostic factors in esophageal cancer.

Authors:  Anna Agnieszka Klimczak-Bitner; Radzisław Kordek; Jan Bitner; Jacek Musiał; Janusz Szemraj
Journal:  Oncol Lett       Date:  2016-09-29       Impact factor: 2.967

2.  Outcome, complications, and mortality of an intrathoracic anastomosis in esophageal cancer in patients without a preoperative selection with a risk score.

Authors:  Ingo Alldinger; Leila Sisic; Marcel Hochreiter; Wilko Weichert; Susanne Blank; Maria Burian; Lars Grenacher; Tom Bruckner; Jens Werner; Markus W Büchler; Katja Ott
Journal:  Langenbecks Arch Surg       Date:  2014-11-20       Impact factor: 3.445

3.  Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach?

Authors:  Susanne Blank; Thomas Schmidt; Patrick Heger; Moritz J Strowitzki; Leila Sisic; Ulrike Heger; Henrik Nienhueser; Georg Martin Haag; Thomas Bruckner; André L Mihaljevic; Katja Ott; Markus W Büchler; Alexis Ulrich
Journal:  Gastric Cancer       Date:  2017-07-06       Impact factor: 7.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.